Benjamin Li
Mar 5, 2010

Mindshare, Aegis Media, OMD and ZenithOptimedia vie for Xian-Janssen Pharmaceutical media planning account in China

BEIJING - Johnson & Johnson owned Xian-Janssen Pharmaceutical Company has called a media planning review in China.

Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Mindshare, Aegis Media, OMD and ZenithOptimedia are understood to be involved in the pitch.

According to agency sources, the account is a “good size and meaningful” and is worth an estimated US$15 million.

OMD holds the media buying account for Johnson & Johnson. The agency won the business in 2007, which also includes Shanghai Johnson & Johnson Pharmaceuticals and Johnson & Johnson Vision Care.

Motilium and Daktarin are among Xian-Janssen Pharmaceutical's main products in China.


 
Source:
Campaign China

Related Articles

Just Published

3 hours ago

Taking the entrepreneurial route: Lessons from a ...

Starting a business is no easy feat, but it's one of the most fulfilling adventures you could undertake. Charu Srivastava, co-founder of TriOn & Co., reflects on her first year leading the business.

3 hours ago

40% women work through high levels of menstrual ...

TOP OF THE CHARTS: The report exposes jarring gaps in workplace safety, working hours and mental health, as well as career progression barriers that continue to plague women in the workplace.

4 hours ago

'Mom's Bed' breaks the silence on caregiver ...

The campaign is a stark reality check on Korea’s caregiving culture that forces countless mothers into cramped, uncomfortable caregiver beds for extended periods—sometimes years.

5 hours ago

Move and win roundup: Week of April 29, 2024

Havas, StackAdapt, Didi, Outbrain, and more in our weekly collection of people moves and account news.